The study included a total of 4,872,295 patients, with 1,281,997 in the SARS-CoV-2 infection group and 3,590,298 in the non-infection group. After propensity score matching, both groups comprised 1,281,997 patients each. Over a 3-year follow-up period, individuals with SARS-CoV-2 infection had significantly higher risks of developing HPV-related cancers compared to those without infection: a 67% increase in cervical cancer, 131% in vaginal cancer, 98% in vulvar cancer, 92% in anal cancer, and 78% in oropharyngeal cancer. Similar trends were observed for carcinoma in situ, with increased risks of 34% for cervical, 61% for vaginal, 74% for vulvar, 96% for anal, and 78% for oropharyngeal carcinoma in situ. Subgroup analyses stratified by age and race demonstrated consistent results.

emphasis mine

you are viewing a single comment's thread
view the rest of the comments

[–] ButtBidet@hexbear.net 3 points 6 months ago (2 children)

Anyway everyone should receive the vaccine that targets 9 strains of HPV, which also causes oral, anal and penile cancer.

This came out in 2015? I think you're aware that most adults, poor people, and boys are going to struggle to get this.

Since the mass withdrawal of testing I don't think there's any validity in this without having done serology

Real question. Are you a researcher? Or do you have a source for this? Sure, serological data would be great, but this is a medical database of millions of people. The researchers don't have direct access to the patients, they don't even have their names. One could do a study using serological data, but the numbers would be much smaller as obviously this is harder and more time consuming.

[–] Le_Wokisme@hexbear.net 2 points 6 months ago (1 children)

This came out in 2015? I think you're aware that most adults, poor people, and boys are going to struggle to get this.

i read "should receive" as a systematic thing not a personal responsibility thing

[–] ButtBidet@hexbear.net 1 points 6 months ago

Fair enough.